Abstract
The current state of the art in post-marketing drug surveillance utilizes voluntarily submitted reports of suspected adverse drug reactions. We present data mining methods that transform unstructured patient notes taken by doctors, nurses and other clinicians into a de-identified, temporally ordered, patient-feature matrix using standardized medical terminologies. We demonstrate how to use the resulting high-throughput data to monitor for adverse drug events based on the clinical notes in the EHR.
Original language | English (US) |
---|---|
Pages (from-to) | 109 |
Journal | AMIA Joint Summits on Translational Science proceedings AMIA Summit on Translational Science |
Volume | 2013 |
State | Published - 2013 |